Onset with ketoacidosis in type 1 diabetes

Diabetes Academy: Resources and Solutions

Assoc. Prof. Dr. Sorin Ioacara Medically reviewed Updated: May 2, 2026 12 min read

Diabetic ketoacidosis is a medical emergency that can occur at the onset of type 1 diabetes, when severe insulin deficiency leads to hyperglycaemia, ketone bodies and metabolic acidosis.

3 in 10
children with ketoacidosis at onset
3–10 days
hospital stay
<2 yrs
the highest-risk age

What is diabetic ketoacidosis?

Diabetic ketoacidosis is an acute complication of diabetes mellitus, with the status of a medical emergency. It occurs when the insulin level drops sharply, beyond a personal threshold. Initially, the drop in insulin reduces glucose utilisation and raises blood glucose. Unable to use glucose efficiently, the body breaks down its fat stores, and the free fatty acids are converted by the liver into ketone bodies. These are acidic and consume the bicarbonate in the blood. Ketoacidosis is thus defined by the combination of hyperglycaemia, the presence of ketone bodies (in blood and urine) and metabolic acidosis [1].

This state is dangerous because it affects several organs at the same time. You lose a lot of water and salts through frequent urination, you become dehydrated rapidly, and potassium becomes unstable. The increased acidity disturbs the function of the heart, the kidneys and the brain. Without timely treatment, ketoacidosis can lead to shock, coma and death. It is often the first sign that the pancreas has stopped producing insulin. You should know that recognising the symptoms early and getting to hospital quickly completely changes how the disease unfolds [1].

How often does ketoacidosis occur at the onset of type 1 diabetes?

Worldwide, ketoacidosis occurs at the onset of type 1 diabetes in roughly three out of ten children and adolescents. The frequency varies greatly from country to country, from below 13–20% in some high-income countries to over 60–80% in many low- and middle-income countries. The difference is explained by access to medical care, the level of public awareness about the warning signs, and how prepared family doctors are to recognise diabetes at the first visit [2].

Ketoacidosis at onset is much more common in young children, especially under 5 years and particularly under 2 years. At this age the classic symptoms (excessive thirst, frequent urination) are hard to spot in a child who still wears a nappy or cannot yet talk. In addition, in young children the disease progresses faster, and dehydration and acidosis can appear within a few days. Ketoacidosis at onset is also more frequent in areas where type 1 diabetes is rarer, because families and doctors are less likely to think of this condition [3].

What are the symptoms of diabetic ketoacidosis at onset?

Symptoms appear gradually, over the course of a few days. At first you notice the classic signs of high blood glucose: intense thirst, frequent urination (including at night), unintentional weight loss, marked tiredness and sometimes blurred vision. In children, bedwetting at night often appears, after a period in which they had already been toilet-trained. As the ketone bodies build up, nausea, repeated vomiting, abdominal pain, Kussmaul breathing (rapid and deep) and a characteristic odour on the breath, similar to ripe fruit or acetone, appear [3].

In advanced stages, the acid in the blood begins to interfere with normal brain function. Confusion, drowsiness and difficulty waking up appear, and finally coma. In young children these symptoms can be mistaken for flu, gastroenteritis or pneumonia, especially when vomiting and rapid breathing are to the fore. If you or someone in your family is far thirstier than usual, together with frequent urination and weight loss, it is important to get to a doctor quickly for a check with a glucose meter. A single measurement can prevent a serious situation from being missed [4].

What blood glucose, pH and bicarbonate values define ketoacidosis?

Diabetic ketoacidosis is defined by three criteria that must be present together. The first is blood glucose above 200 mg/dL (11.1 mmol/L) or an already known diagnosis of diabetes. The second is increased acidity of the blood, expressed as a venous pH below 7.3 or a serum bicarbonate below 18 mEq/L (mmol/L). The third criterion is the presence of ketone bodies, measured either in the blood (beta-hydroxybutyrate above 3 mmol/L) or in the urine (at least two pluses on the rapid test). These tests are done quickly in the emergency department, from a sample of venous blood and a urine test [1].

The severity of ketoacidosis is graded by the blood pH. The mild form corresponds to a pH between 7.2 and 7.3, the moderate form to a pH between 7.1 and 7.2, and the severe form to a pH below 7.1. The lower the pH, the greater the dehydration and the risk of complications. These tests are obtained in under an hour in any hospital with an emergency department. If you have suggestive symptoms, getting to hospital quickly allows the diagnosis to be confirmed and treatment to be started within the first hours, before the condition worsens [1].

What are the causes of ketoacidosis at the onset of type 1 diabetes?

At the onset of type 1 diabetes, the main cause of ketoacidosis is the lack of a diagnosis and, as a result, of insulin treatment. The immune system has already destroyed most of the pancreatic beta cells, but the disease has not yet been recognised. Without insulin, blood glucose rises, the body burns fat and ketone bodies appear. In many situations the initial symptoms are mistaken for other, more common conditions, such as a urinary infection, gastroenteritis or flu. The lack of awareness in the family, and sometimes among doctors, of the warning signs (thirst, frequent urination, weight loss) is a major reason an early diagnosis is missed [5].

Alongside the delay in diagnosis, there are also factors that increase the risk of ketoacidosis at onset. Younger age is the most important factor, especially under 2 years, when the symptoms are hard to spot. Not having a close relative with type 1 diabetes also matters, because families with no experience of caring for this disease recognise the warning signs more slowly. A low socioeconomic status, limited access to medical care and living in areas where type 1 diabetes is rare also raise the risk of a delayed diagnosis. Concurrent infections can speed up the onset of ketoacidosis in a person who already has undiagnosed diabetes [3].

How serious can ketoacidosis at onset be?

Diabetic ketoacidosis is a serious medical condition, an emergency that must be treated in hospital. The lower the pH and the more severe the dehydration, the higher the risk of complications. The most important complications are cerebral oedema (especially in children under 5 years), acute kidney failure due to dehydration, heart rhythm disturbances linked to potassium changes and a collapse in blood pressure from the reduced blood volume (hypovolaemic shock). The imbalance of salts in the blood, especially the drop in potassium after insulin treatment is started, needs careful monitoring [6].

In countries with good access to paediatric care and intensive care, mortality from ketoacidosis in children and adolescents is very low, close to zero. In regions with limited access to hospital, mortality remains higher and is due to late presentation or to the inability to provide continuous monitoring. Cerebral oedema is the main cause of death and can leave neurological after-effects in some of those who survive. The message to take away is that prompt treatment, with careful monitoring and a well-prepared medical team, maximises your chances of a full recovery [6].

What is cerebral oedema and why does it occur in ketoacidosis?

Cerebral oedema means swelling of the brain caused by water building up in and between the nerve cells. It is the most feared complication of diabetic ketoacidosis and occurs above all in children (especially under 5 years) and in the elderly. The mechanism involves changes in blood glucose, and therefore in blood osmolality, that happen too quickly. For this reason, rebalancing is carried out slowly and in a controlled way, and insulin is given so as to avoid too rapid a fall in blood glucose [6].

Cerebral oedema usually appears in the first 4 to 12 hours after treatment is started, but it can sometimes appear later. Warning signs include severe headache, vomiting that returns after the condition seemed to be improving, behavioural changes, drowsiness, a slowing heart rate and a rise in blood pressure. Medical staff watch carefully for these signs. If they appear, treatment includes hypertonic saline or mannitol, raising the head of the bed and reassessment in intensive care. Today, following the slow rebalancing protocol has greatly reduced the risk of this complication [6].

How is ketoacidosis treated in hospital?

The treatment of ketoacidosis rests on four pillars. The first pillar is fluid resuscitation, with fluids given intravenously, usually as normal saline (0.9% sodium chloride). The water deficit is replaced gradually over 24–48 hours. The second pillar is insulin given as a continuous intravenous infusion, usually at a rate of 0.05–0.1 units/kg/hour, using regular human insulin. The third pillar is potassium replacement, added to the infusion fluids, because insulin and the change in blood acidity push potassium from the blood into the cells. The fourth pillar is monitoring of blood glucose (every 1–2 hours) and of electrolytes, pH and bicarbonate (every 2–4 hours) [1].

Sodium bicarbonate is not given routinely (only at a pH below 7), because it is associated with a higher risk of cerebral oedema. Ketoacidosis is considered resolved when the pH is above 7.3, bicarbonate is above 18 mmol/L, ketone bodies drop below 1 mmol/L and the patient can tolerate eating. At this point the switch to insulin given under the skin is made. Long-acting basal insulin (glargine or degludec) can be added early to the rapid-acting one (even before ketoacidosis has fully resolved), to shorten the time to resolution and to reduce the total need for insulin and fluids [7].

How long does hospital stay for ketoacidosis at onset last?

The hospital stay for ketoacidosis at the onset of type 1 diabetes usually lasts between 3 and 10 days, depending on the severity of the ketoacidosis and on the education programme of the centre. In some centres with structured programmes, the stay can reach 14 days, in order to include complete therapeutic education. The stay has two phases. The first phase, of 12–36 hours, is dedicated to correcting the ketoacidosis, careful monitoring and specialised intensive care. Ketoacidosis usually resolves biochemically within the first 12–24 hours. The second phase, of several days, is dedicated to starting subcutaneous insulin treatment and beginning therapeutic education [4].

Educating the family is just as important as the treatment itself. Together with your loved ones, you will learn what type 1 diabetes is, how insulin is given with a pen or syringe, how injection sites are rotated, how blood glucose is monitored (by finger-prick or with a continuous monitoring system), how to recognise and treat hypoglycaemia, and how to count carbohydrates and adjust doses. You will be given sick-day rules, instructions for using glucagon and, possibly, a written plan for school or work. The team is multidisciplinary (specialist doctor, diabetes educator nurse, dietitian, psychologist), and after discharge follow-up visits take place every 3 months [4].

How can ketoacidosis be prevented in the siblings of children with type 1 diabetes?

The brothers and sisters of a patient with type 1 diabetes have a higher risk of developing the disease than the general population. Type 1 diabetes begins long before symptoms appear, through the autoimmune destruction of the beta cells. This phase can be detected by looking in the blood for specific autoantibodies (GAD, IAA, IA-2, ZnT8). If a person has two or more of these autoantibodies, the risk of developing clinical diabetes in the following years is very high. Screening with autoantibodies is recommended for first-degree relatives of any patient with type 1 diabetes. International programmes offer this screening, such as TrialNet, Fr1da, ASK, GPPAD and ELSA [8].

The disease is today divided into three stages. Stage 1 means the presence of at least two autoantibodies with normal blood glucose. Stage 2 adds blood glucose disturbances (impaired fasting glucose, impaired glucose tolerance or a prediabetic rise in HbA1c), but without symptoms. Stage 3 is the clinical disease, when symptoms appear and insulin treatment becomes necessary. Identifying patients in stage 1 or 2 allows regular monitoring, education about the warning signs and an action plan, so that a stage 3 diagnosis is made before ketoacidosis sets in. As part of the action plan, measuring blood ketones (beta-hydroxybutyrate) at home — with portable meters or, more recently, with continuous ketone monitoring systems — can help detect ketoacidosis early [9]. Talking to your diabetes doctor about screening, monitoring and the treatment options for your first-degree relatives is the most effective step you can take to protect your brothers and sisters [10].

Conclusions

  • Diabetic ketoacidosis at the onset of type 1 diabetes is a medical emergency, defined by hyperglycaemia, ketone bodies and metabolic acidosis [1].
  • It appears at the moment type 1 diabetes is diagnosed in roughly 3 out of 10 children, though with large geographical differences [2].
  • Recognising intense thirst, frequent urination and unintentional weight loss early prevents the severe forms [3] [4].
  • Cerebral oedema is the main serious complication of ketoacidosis, especially in children under 5 years. The protocol of slow acid-base and fluid-electrolyte rebalancing greatly reduces this risk [6].
  • Screening first-degree relatives with autoantibodies can help prevent ketoacidosis at the diagnosis of type 1 diabetes [8] [10].

You might also be interested in:

Other pages available in the type 1 diabetes diagnosis and staging domain

References

  1. Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835-856. PubMed
  2. Niechciał E, Bielecki M, Geppert A, et al. Changes in the Prevalence of Diabetes Ketoacidosis at the Onset of Type 1 Diabetes in Polish Children: A Comparative Analysis Between Two 9-Year Periods-2006-2014 and 2015-2023. Pediatr Diabetes. 2025;2025:8927409. PubMed
  3. Lan YY, Kovinthapillai R, Kędzia A, Niechciał E. Enhancing Primary Care Recognition of Type 1 Diabetes in Children: Diagnostic Challenges and Strategies to Prevent Diabetic Ketoacidosis. J Clin Med. 2026;15(2):533. PubMed
  4. American Diabetes Association Professional Practice Committee. 14. Children and Adolescents: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S297-S320. PubMed
  5. Arhire AI, Papuc T, Ioacara S, Gradisteanu Pircalabioru G, Barbu CG. Unveiling the gut connection: Exploring the link between microbiota and type 1 diabetes onset in pediatric patients. Biomed Rep. 2025;24(1):1. PubMed
  6. Siddiqui EU, Othman A, Tashkandi AH, et al. Pediatric diabetic ketoacidosis and cerebral oedema: a systematic review. Ann Pediatr Endocrinol Metab. 2025;30(5):242-249. PubMed
  7. Nguyen B, Quon S, Dhaliwal B, Warwas M, Stafford S. Early versus late initiation of long-acting insulin in paediatric and adult diabetic ketoacidosis: A systematic review and meta-analysis of randomised control trials. Diabetes Obes Metab. 2026;28(5):3655-3663. PubMed
  8. Martinenghi S, Merolla A, Grogan P, et al. Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in Italy. Diabetologia. 2025;68(9):1889-1898. PubMed
  9. Dhatariya K, Bergenstal RM, Al-Sofiani M, et al. Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology. Lancet Diabetes Endocrinol. 2026;14(1):82-92. PubMed
  10. Hussain S, Tree T, Mathieu C, et al. An international consensus on screening and monitoring early-stage type 1 diabetes: A roadmap to European implementation. Diabetes Obes Metab. 2026;28(5):3535-3556. PubMed